The EPS Group, consisting of EPS Vascular AB, EP Endovascular AB and EPS Vascular Oy, sells and distributes market-leading medical devices with cardiovascular and neurovascular applications in Sweden, Denmark, Norway, Finland and the Baltic states. The EPS Group had a turnover of approximately MSEK 125 in the 2018 financial year.
Uniphar plc is listed on the Dublin Stock Exchange and has a turnover of EUR 1.5 billion. The acquisition is part of Uniphar’s growth strategy for Europe.
“The support we have received from the team at Lindahl has enabled EPS to complete a sale to Uniphar in Ireland. It was a long, complex deal involving extensive due diligence. Lindahl’s team has provided us with incredible assistance, and we are grateful that they were on our side of the negotiating table,” says Joakim Eriksson.
Lindahl has been an advisor to the sellers in the transaction and our team has consisted of Magnus Ramberg (client manager), Svante Liljedahl (project manager, M&A), Viktor Wihlstrand (M&A), Christer Hagberg (labour law) & Isabelle Selemba (M&A).
